Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04898036

Phototherapy For Treatment Of Raynaud's Phenomenon

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

To determine if blue light therapy can improve the symptoms of Raynaud's phenomenon, and provide parameters for ultimately designing commercial treatment devices, an investigational stationary phototherapy unit was designed and built.

Detailed description

The purpose of this study is to test the efficacy of blue light phototherapy for the treatment of Raynaud's phenomenon (RP) in human participants. The specific aim is to see if phototherapy treatment applied to the hands will reduce the symptoms that RP participants experience. This will be measured through the use of a visual analog scale (VAS) of both pain and numbness. This study will also help to infer whether blue light phototherapy causes vasodilation through infrared thermal imaging of the hands and continuous measurement of skin temperature with a surface thermistor. Together, the visual analog scale (VAS) and infrared thermal imaging contribute to the objective of deducing whether blue light phototherapy can lead to reduced RP symptoms due to vasodilation of blood vessels.

Conditions

Interventions

TypeNameDescription
DEVICEBlue Light TherapyThis phototherapy device (PTD-1) consists of a Plexiglas hand compartment (cleanable) enclosed in a powder-coated steel cabinet. Within the cabinet are two blue LED panels located above and below the hand compartment to illuminate the hands.
DEVICESham Light TherapyTo turn the device into a sham mode, a thin opaque liner can be inserted which will block light from illuminating the hands.

Timeline

Start date
2022-08-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2021-05-24
Last updated
2023-01-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04898036. Inclusion in this directory is not an endorsement.